Delivery Order SPE2DB22D3301-SPE2DB24FY1YS
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ROTARIX vaccine oral syringes. The $3,660.63 delivery order has a completion date of January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $40,202.40 to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,161,303 units of the ROTARIX vaccine oral syringe, 1.5 mL. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical...
- The Defense Logistics Agency has awarded a firm fixed price delivery order worth $7,880.13 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ROTARIX VACCINE ORAL SYRINGE 1.5ML. This order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $10,268.58 for the provision of ROTARIX vaccine oral syringes. The award has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this order is fulfilled under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,689.70 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide ROTARIX vaccine oral syringes. The contract has a completion date of January 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and is based in Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to supply the ROTARIX vaccine oral syringe 1.5ML. The $5,424.14 award has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the ROTARIX VACCINE ORAL SYRINGE 1.5ML. The contract has a potential value of $13,074.67 and a completion date of January 31, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,640,750 units of the ROTARIX vaccine in 10-dose kits. The $2,554.83 order has a completion date of February 14, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, that serves as the primary...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the ROTARIX vaccine oral syringes in 1.5 mL size. The contract has a potential value of $15,227.75 and a completion date of February 27, 2024. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- This firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, provides the Rotarix vaccine in oral syringes to DLA Troop Support Medical. The $3,661.95 contract has a performance period through March 2024 and is not associated with any set-aside designations. In addition to this delivery order, AmerisourceBergen Drug Corp holds an indefinite delivery contract...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY1YSDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $27,493.49 to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the ROTARIX vaccine oral syringes (1.5mL) with a completion date of March 6, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as Amerisourcebergen's primary contract vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.5k | 3/5/24 |